Pesquisas alternativas:
compared case » compared cases (Expandir a Pesquisa), compare care (Expandir a Pesquisa), companies case (Expandir a Pesquisa)
compared can » compared law (Expandir a Pesquisa), compared cases (Expandir a Pesquisa), companies can (Expandir a Pesquisa)
gel compared » model compared (Expandir a Pesquisa), level compared (Expandir a Pesquisa), gel prepared (Expandir a Pesquisa)
compared a » compared _ (Expandir a Pesquisa), compare a (Expandir a Pesquisa), compare _ (Expandir a Pesquisa)
3 daily » a daily (Expandir a Pesquisa), 2 daily (Expandir a Pesquisa), g daily (Expandir a Pesquisa)
3 gel » _ gel (Expandir a Pesquisa), i gel (Expandir a Pesquisa), a gel (Expandir a Pesquisa)
a non » _ non (Expandir a Pesquisa)
compared case » compared cases (Expandir a Pesquisa), compare care (Expandir a Pesquisa), companies case (Expandir a Pesquisa)
compared can » compared law (Expandir a Pesquisa), compared cases (Expandir a Pesquisa), companies can (Expandir a Pesquisa)
gel compared » model compared (Expandir a Pesquisa), level compared (Expandir a Pesquisa), gel prepared (Expandir a Pesquisa)
compared a » compared _ (Expandir a Pesquisa), compare a (Expandir a Pesquisa), compare _ (Expandir a Pesquisa)
3 daily » a daily (Expandir a Pesquisa), 2 daily (Expandir a Pesquisa), g daily (Expandir a Pesquisa)
3 gel » _ gel (Expandir a Pesquisa), i gel (Expandir a Pesquisa), a gel (Expandir a Pesquisa)
a non » _ non (Expandir a Pesquisa)
1
Publicado no Cell Prolif
(2002)
“...) and SPF (r = 0.77). P53 immunoreactivity was present in 71.4% of the tumours, whereas 39.3% of cases were...”Obter o texto integral
Obter o texto integral
Artigo